| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0024-3205(87)90446-2 |
| P698 | PubMed publication ID | 3613836 |
| P2093 | author name string | Yu PH | |
| Boulton AA | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 675-682 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Irreversible inhibition of monoamine oxidase by some components of cigarette smoke | |
| P478 | volume | 41 |
| Q34377010 | 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). |
| Q28291245 | A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers* |
| Q42641590 | A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch |
| Q48424971 | An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo |
| Q47337150 | Both low and high activities of platelet monoamine oxidase increase the probability of becoming a smoker |
| Q34063791 | Brain monoamine oxidase A inhibition in cigarette smokers |
| Q44558966 | Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin. |
| Q35814371 | Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals |
| Q41159888 | Comparison of blood aldehyde dehydrogenase activities in moist snuff users, cigarette smokers and nontobacco users |
| Q38617975 | Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence |
| Q77457963 | Crohn's disease remission with phenelzine treatment |
| Q34064063 | Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei |
| Q37281925 | Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers |
| Q28391911 | Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects |
| Q33815480 | Hypothesis for temporal displacement of metabolic and neuronal accommodation in smoking addiction |
| Q73292750 | Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke |
| Q34307652 | Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration |
| Q67767138 | Inhibition of human blood aldehyde dehydrogenase activity by cigarette-smoke condensate |
| Q24322939 | Inhibition of monoamine oxidase B in the brains of smokers |
| Q34558819 | Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake |
| Q44163654 | Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation |
| Q36161343 | Low monoamine oxidase B in peripheral organs in smokers |
| Q33845951 | Monoamine oxidase and cigarette smoking. |
| Q46881166 | Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. |
| Q24614980 | Monoamine oxidase: from genes to behavior |
| Q34464750 | Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition |
| Q41101822 | Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity |
| Q33784175 | Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys |
| Q43772380 | Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty |
| Q34116547 | Polymorphisms in genes involved in neurotransmission in relation to smoking |
| Q30932949 | Risk factors for the neurohumoral alterations underlying personality disturbances |
| Q54117517 | Role of adrenergic nervous system in cigarette smoke-induced bronchoconstriction in guinea pigs. |
| Q36965671 | Smoking and Parkinson's Disease - A New Perspective |
| Q57171561 | Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science |
| Q48389819 | Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease. |
| Q44894571 | Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase |
| Q26823707 | The DNA methylation signature of smoking: an archetype for the identification of biomarkers for behavioral illness |
| Q47724790 | The association of measures of the serotonin system, personality, alcohol use, and smoking with risk-taking traffic behavior in adolescents in a longitudinal study |
| Q36288415 | The biometric measurement of alcohol consumption |
| Q59619140 | The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity |
| Q74308991 | The genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity |
| Q43991249 | The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets |
| Q41756316 | Toxicity of aliphatic amines: structure-activity relationship |
Search more.